Skip to main content
Neuland Laboratories Limited. logo

Neuland Laboratories Limited. — Investor Relations & Filings

Ticker · NEULANDLAB ISIN · INE794A01010 LEI · 335800AVHZURTYQ17N08 BSE.NS Manufacturing
Open in API
Filings indexed 943 across all filing types
Latest filing 2026-01-21 Regulatory Filings
Country IN India
Listing BSE.NS NEULANDLAB

About Neuland Laboratories Limited.

https://www.neulandlabs.com

Neuland Laboratories Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and provides comprehensive Custom Manufacturing Solutions (CMS). The company focuses on complex chemistry and high-quality standards, operating state-of-the-art manufacturing facilities that comply with international regulatory requirements, including those of the USFDA and EDQM. Its product portfolio spans diverse therapeutic areas such as cardiovascular, central nervous system, anti-infectives, and antiasthmatics. Neuland supports pharmaceutical companies globally through the entire lifecycle of a drug, from early-stage clinical development to commercial-scale production. By leveraging advanced technical expertise and a robust quality management system, the organization delivers reliable chemical synthesis and process optimization services to both innovator and generic drug manufacturers.

Recent filings

Filing Released Lang Actions
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to approve unaudited financial results for a quarter and nine months period. It is addressed to stock exchanges and references compliance with SEBI regulations. The document is short (1493 characters) and serves as an announcement of an upcoming event rather than containing actual financial data or results. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) as it is a general regulatory announcement about the Board Meeting and financial results approval.
2026-01-21 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2025. It is a compliance certificate from the Registrar and Share Transfer Agent certifying that details of securities dematerialized/rematerialized have been furnished to stock exchanges. The document is short (3203 characters) and primarily a regulatory compliance certificate rather than a financial report or announcement. It does not contain financial statements, management discussion, or other report content. It is not an announcement of a report but a regulatory filing required by SEBI regulations. Therefore, it fits best under Regulatory Filings (RNS).
2026-01-02 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges and the company secretary regarding the re-lodgement of transfer requests of physical shares. It references a SEBI circular and provides a status update on the number of requests received, processed, approved, and rejected for the month ended December 31, 2025. The document is short (2514 characters) and serves as an informational update to regulatory bodies and stock exchanges. It does not contain financial statements, audit information, management discussion, or detailed financial data. It is not a report itself but an official regulatory communication related to share transfer processes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2026-01-02 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about the closure of the trading window pursuant to the company's Insider Trading Code. It mentions the upcoming declaration of financial results for the quarter and nine months ended December 31, 2025, but does not contain any financial data or results itself. The document is short (1189 characters) and serves as an announcement related to trading restrictions ahead of financial results disclosure. Therefore, it is neither a financial report nor a detailed regulatory filing but an announcement related to trading compliance. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-26 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding a regulatory compliance matter under the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015. It mentions a newspaper advertisement about a special window for re-lodgement of transfer requests of physical shares. The content is primarily an announcement informing the exchanges about the publication of this advertisement for shareholders' information and records. There is no financial data, no detailed report, no management discussion, or earnings information. The document is relatively short (about 14,334 characters) and serves as a notification or announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-19 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of analyst and institutional investor meetings. It references Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of upcoming investor meetings, not a financial report, earnings release, or detailed presentation. The document length is only 1513 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.